Searched for
RAVINDRANATH KANCHERLA
Ravindranath Kancherla on why most healthcare innovation never reaches patients and how India can change thatDr. Ravindranath Kancherla, the founder of Global Hospitals and Global HealthX reflects on how India can emerge as a global proving ground ...- Buy Laurus Labs, target price Rs 710: Bajaj BrokingBajaj Broking recommends buying Laurus Labs with a target price of Rs 710. The current price is Rs 565.4. Laurus Labs expects significant g...
- Unaprime buys Tata Healthcare's 43.5% in Lokmanya HospitalsLokmanya Hospitals has five hospitals located in Pune, Pimpri-Chinchwad and Kolhapur. The hospitals have an existing capacity of 300 beds a...
- Healthcare veteran Dr Ravindranath Kancherla invests in Makers HiveThe company said that Dr. Ravindranath's investment signifies the successful conclusion of Makers Hive's bridge round, positioning the orga...
- IHH Healthcare to acquire remaining stake in Ravindranath GE Medical Associates for Rs 740 crMalaysia's IHH Healthcare Bhd on Friday said it will acquire the remaining stake in hospital chain operator Ravindranath GE Medical Associa...
- Buy Laurus Labs, target price Rs 338.8: ICICI DirectLaurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 18060.97 Crore) operating in Pharmaceuticals se...
- Buy Laurus Labs, target price Rs 355: Sharekhan by BNP ParibasLaurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 18060.97 Crore) operating in Pharmaceuticals se...
- Hold Laurus Labs, target price Rs 323: Sharekhan by BNP ParibasLaurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 17134.49 Crore) operating in Pharmaceuticals se...
- Buy Laurus Labs, target price Rs 395: Axis SecuritiesLaurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 17403.81 Crore) operating in Pharmaceuticals se...
- Buy Laurus Labs, target price Rs 325: Sharekhan by BNP ParibasHigher tops and higher bottoms along with a bullish crossover in its momentum indicator MACD.
- Sell Laurus Labs, target price Rs 350: Kotak Institutional EquitiesLaurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 22515.36 Crore) operating in Pharmaceuticals se...
- Buy Laurus Labs, sequential targets Rs 590- 633: HDFC SecuritiesBuy Laurus Labs Ltd. at a price sequential targets Rs 590- 633 .
Load More
